Invention Grant
- Patent Title: Method for assessing the response to PD-1/PDL-1 targeting drugs
-
Application No.: US16631848Application Date: 2018-07-17
-
Publication No.: US11293066B2Publication Date: 2022-04-05
- Inventor: Salem Chouaib , Stéphanie Buart
- Applicant: INSTITUT GUSTAVE ROUSSY
- Applicant Address: FR Villejuif
- Assignee: INSTITUT GUSTAVE ROUSSY
- Current Assignee: INSTITUT GUSTAVE ROUSSY
- Current Assignee Address: FR Villejuif
- Agency: Saliwanchik, Lloyd & Eisenschenk
- Priority: EP17305952 20170718
- International Application: PCT/EP2018/069332 WO 20180717
- International Announcement: WO2019/016174 WO 20190124
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C12Q1/6886
Abstract:
The present invention relates to a method for assessing the response to PD-1/PDL-1 targeting drugs based on the differential expression levels of BINP3 and GBE1.
Public/Granted literature
- US20200157639A1 METHOD FOR ASSESSING THE RESPONSE TO PD-1/PDL-1 TARGETING DRUGS Public/Granted day:2020-05-21
Information query
